TELEFLEX INCORPORATED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 229.3 USD | +4.29% |
|
+5.21% | -7.99% |
| 01:51pm | Truist Raises Price Target on Teleflex to $240 From $235, Maintains Hold Rating | MT |
| 07-09 | Truist Securities Adjusts Price Target on Teleflex to $235 From $219, Maintains Hold Rating | MT |
Teleflex Incorporated specialises in the designing, manufacturing and selling of single-use medical devices for hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. Products are sold under the brand names Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch® and Weck®. Net sales break down by category of products as follows:
- interventional cardiology, radiology and urology products (26.5%);
- vascular access solutions (25.9%);
- surgical devices (12.5%);
- anesthesia products (11.9%);
- other (23.2%).
Net sales are distributed geographically as follows: the United States (61.8%), Europe (25.5%), Asia-Pacific (9.1%) and other (3.6%).
Calendar
2024-07-24
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
219.8
USD
Average target price
248.1
USD
Spread / Average Target
+12.86%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -8.05% | 10.36B | |
| -6.68% | 179B | |
| -5.20% | 98.84B | |
| -5.38% | 65.34B | |
| +15.46% | 45.41B | |
| -6.47% | 44.94B | |
| +9.74% | 43.76B | |
| +14.01% | 29.01B | |
| +19.39% | 25.65B | |
| -6.53% | 23.32B |
- Stock Market
- Equities
- TFX Stock
- News Teleflex Incorporated
- Truist Raises Price Target on Teleflex to $240 From $235, Maintains Hold Rating
